Bpifrance SA - Q2 2022 holdings

$2.68 Billion is the total value of Bpifrance SA's 9 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
STLA  STELLANTIS NV$2,358,303,000
-25.5%
192,703,9070.0%88.10%
-0.5%
CSTM  CONSTELLIUM NVcl a$216,563,000
-26.6%
16,393,9030.0%8.09%
-2.0%
CRTO  CRITEO S Aspons ads$66,338,000
-10.4%
2,718,7520.0%2.48%
+19.6%
VECT  VECTIVBIO HOLDING AG$15,154,000
+14.7%
2,806,2170.0%0.57%
+53.0%
SQNS  SEQUANSCOMMUNICATIONS S Aspons ads$8,877,000
-11.5%
3,300,0180.0%0.33%
+18.1%
 MIRION TECHNOLOGIES INC$7,410,000
-28.6%
1,286,4460.0%0.28%
-4.5%
VCYT  VERACYTE INTERNATIONAL$3,030,000
-27.8%
152,2610.0%0.11%
-3.4%
CLLS  CELLECTISspons ads$1,205,000
-37.7%
425,7260.0%0.04%
-16.7%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings